Palobiofarma

Barcelona, Spain · Founded 2005 · Privately Held (backing)

Developer of adenosine receptor modulators designed to advance treatments for orphan and neurological diseases. Palobiofarma is based in Barcelona, Spain and was founded in 2005. Its last known valuation is $79.3 million. It has raised $21.1 million.

Last price · $/share
—
Implied valuation
$79.3M
Total raised
$21.1M
Last round
—

Who backs Palobiofarma?

15 investors
InvestorType
European UnionOther
INNVIERTE SICCOther
Inveready Asset ManagementVenture capital
Sociedad de Desarrollo de NavarraOther
Agencia de Innovación—
European Innovation Council (Belgium)—
Everis Group—
FPWR—
Financiación e Internacionalización Empresarial—
Fitalent—
+ 5 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Palobiofarma investors

15 investors are on record for Palobiofarma, including European Union, INNVIERTE SICC, Inveready Asset Management and Sociedad de Desarrollo de Navarra.

Free account
More of Palobiofarma with a free account
  • ·The complete investor list: 15 names
  • ·Watch Palobiofarma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 15 firms already write checks for companies like Palobiofarma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View